Login
$CYTK
$52.61 -$0.56 (1.05%) After hours

$CYTK SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 Form 4: Parshall B Lynne, Director

Sold 5,000 shares ($274K)

10 Nov 2026 SCHEDULE 13G
09 Nov 2026 144
04 Nov 2026 10-Q
04 Nov 2026 8-K: Results of Operations and Financial Condition

Expect to Submit Supplemental NDA for Aficamten in Non-Obstructive HCM in Q4 2026 and Type II Variation in the European Union in Early 2027

03 Nov 2026 Form 4: Malik Fady Ibraham, EVP Research & Development

Received 3,500 shares by exercise or conversion ($27.3K) · Sold 3,500 shares ($220K)

02 Nov 2026 Form 4: Blum Robert I, Director

Received 7,500 shares by exercise or conversion ($79.5K) · Sold 7,500 shares ($471K)

20 Oct 2026 Form 4: Wysenski Nancy, Director

Received 97 shares as a grant or award ($6.2K)

20 Oct 2026 Form 4: Kaye Edward M. Md, Director

Received 195 shares as a grant or award ($12.5K)

20 Oct 2026 Form 4: Harrington Robert Arthur, Director

Received 195 shares as a grant or award ($12.5K)

20 Oct 2026 Form 4: Daly James M, Director

Received 195 shares as a grant or award ($12.5K)

20 Oct 2026 Form 4: Wierenga Wendell, Director

Received 97 shares as a grant or award ($6.2K)

20 Oct 2026 Form 4: Henderson John T, Director

Received 352 shares as a grant or award ($22.5K)

20 Oct 2026 144
20 Oct 2026 Form 4: Malik Fady Ibraham, EVP Research & Development

Received 3,500 shares by exercise or conversion ($27.3K) · Sold 3,500 shares ($224K)

13 Oct 2026 Form 4: Blum Robert I, Director

Received 7,500 shares by exercise or conversion ($79.5K) · Sold 7,500 shares ($472K)

13 Oct 2026 144
06 Oct 2026 Form 4: Malik Fady Ibraham, EVP Research & Development

Received 3,500 shares by exercise or conversion ($27.3K) · Sold 3,500 shares ($215K)

28 Sep 2026 Form 4: Blum Robert I, Director

Received 7,500 shares by exercise or conversion ($79.5K) · Sold 7,500 shares ($491K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support